Get started
Author

Minhui Zeng

Observed names: Min‐Hui Zeng, Zeng, Minhui
ORCID: 0000-0001-7394-6188
Observed ORCID: 0000-0001-7394-6188
OpenAlex ID: A5041344093
LncRNA NBR2 aggravates hepatoblastoma cell malignancy and promotes cell proliferation under glucose starvation through the miR-22/TCF7 axis
2021 · Chengguang Zhu, Xiangling He, et al. · Cell Cycle · 18
Clinical characteristics and prognosis analysis of patients with de novo ASXL1 ‐mutated AML treated with the C‐HUNAN‐AML ‐15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group
2023 · Minhui Zeng, Keke Chen, et al. · Cancer Medicine · 5
PDF
HAND2-AS1 plays a tumor-suppressive role in hepatoblastoma through the negative regulation of CDK1
2024 · Keke Chen, Yalan You, et al. · Heliyon · 2
The properties of cholesterol-modified pullulan nanoparticles with different PEG coatings and their anti-hepatoblastoma cell effects
2022 · Xin Tian, Xiangling He, et al. · Materials Technology · 2
A type of brain-targeting nano-formulation and its anti-tumour effect in paediatric brain tumour cells
2024 · Xin Tian, Taoxiang Shi, et al. · Materials Technology · 1
PDF
Real‐world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG[PLUS]‐CML 2023
2025 · Zhong Fan, Qi‐Wen Chen, et al. · Cancer
PDF
LncRNA NBR2 aggravates hepatoblastoma cell malignancy and promotes cell proliferation under glucose starvation through the miR-22/TCF7 axis
2021 · Zhu, Chengguang, He, Xiangling, et al. · Figshare
Works count: 7
Citation count: 28
H-index: 2
I10-index: 1
Year
Topic
Type